Outset Medical (NASDAQ:OM – Get Rating) had its target price dropped by research analysts at Cowen from $33.00 to $22.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Cowen’s price target suggests a potential upside of 25.64% from the stock’s previous close.
A number of other analysts also recently commented on the company. Stifel Nicolaus lowered their target price on Outset Medical from $30.00 to $24.00 in a research note on Monday, July 18th. The Goldman Sachs Group lowered their target price on Outset Medical from $48.00 to $34.00 and set a “buy” rating on the stock in a research note on Wednesday, August 3rd. Finally, Morgan Stanley lowered their price target on Outset Medical from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 11th.
Outset Medical Stock Up 17.5 %
Shares of OM opened at $17.51 on Wednesday. Outset Medical has a 52 week low of $11.41 and a 52 week high of $55.41. The company has a quick ratio of 5.29, a current ratio of 6.26 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $840.60 million, a price-to-earnings ratio of -5.12 and a beta of 1.60. The stock’s 50-day moving average price is $15.68 and its 200-day moving average price is $19.05.
Hedge Funds Weigh In On Outset Medical
Outset Medical Company Profile
Outset Medical, Inc, a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
- Get a free copy of the StockNews.com research report on Outset Medical (OM)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Coupang Stock And Why You Should Care
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.